UnitedHealth Group Incorporated (UNH)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $365.09B
Last updated: Nov 17, 2026 at 11:06 AM ET
UnitedHealth Group Incorporated (UNH) Earnings: Report Dates and Results
UnitedHealth Group (UNH) is expected to report earnings on Jan 25, 2027. In the quarter ended Sep 30, 2026, UnitedHealth Group reported EPS of $4.69, above the $4.12 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
UNH has an expected report date of Jan 25, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 8.5% above the $2.11 reported for the quarter ended Dec 31, 2025.
UNH Earnings Call
The latest UNH earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, UNH beat 37, missed 2 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $112.69B, down 0.4% from $113.16B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $4.69 | $4.12 | $3.90 - $4.56 | +13.84% | Beat | +60.6% | 23 | 2 up, 1 down | Oct 13, 2026 | $112.69B |
| Jun 30, 2026 | $6.38 | $4.94 | $4.24 - $5.22 | +29.15% | Beat | +56.4% | 23 | 2 up, 3 down | Jul 16, 2026 | $112.03B |
| Mar 31, 2026 | $7.23 | $6.60 | $5.01 - $6.98 | +9.55% | Beat | +0.4% | 23 | N/A | Apr 21, 2026 | $111.72B |
| Dec 31, 2025 | $2.11 | $2.11 | $2.02 - $2.31 | 0.00% | In line | -69.0% | 24 | 1 up, 1 down | Jan 27, 2026 | $113.22B |
| Sep 30, 2025 | $2.92 | $2.81 | $2.22 - $3.57 | +3.91% | Beat | -59.2% | 23 | 2 up, 3 down | Oct 28, 2025 | $113.16B |
| Jun 30, 2025 | $4.08 | $4.45 | $3.39 - $5.48 | -8.31% | Miss | -40.0% | 22 | 1 up, 8 down | Jul 29, 2025 | $111.62B |
| Mar 31, 2025 | $7.20 | $7.29 | $5.89 - $7.91 | -1.23% | Miss | +4.2% | 22 | 2 up, 1 down | Apr 17, 2025 | $109.58B |
| Dec 31, 2024 | $6.81 | $6.74 | $6.42 - $7.00 | +1.04% | Beat | +10.6% | 23 | 3 up, 4 down | Jan 16, 2025 | $100.81B |
| Sep 30, 2024 | $7.15 | $7.03 | $6.85 - $7.11 | +1.71% | Beat | +9.0% | 23 | 1 up, 0 down | Oct 15, 2024 | $100.82B |
| Jun 30, 2024 | $6.80 | $6.63 | $5.86 - $6.87 | +2.56% | Beat | +10.7% | 21 | 0 up, 1 down | Jul 16, 2024 | $98.86B |
| Mar 31, 2024 | $6.91 | $6.62 | $6.22 - $6.80 | +4.38% | Beat | +10.4% | 22 | 1 up, 1 down | Apr 16, 2024 | $99.80B |
| Dec 31, 2023 | $6.16 | $5.99 | $5.90 - $6.02 | +2.84% | Beat | +15.4% | 19 | 0 up, 2 down | Jan 12, 2024 | $94.43B |
| Sep 30, 2023 | $6.56 | $6.35 | $6.14 - $6.73 | +3.31% | Beat | +13.3% | 20 | 0 up, 1 down | Oct 13, 2023 | $92.36B |
| Jun 30, 2023 | $6.14 | $5.98 | N/A | +2.68% | Beat | +10.2% | 22 | 0 up, 9 down | Jul 14, 2023 | $92.90B |
| Mar 31, 2023 | $6.26 | $6.08 | $5.39 - $7.33 | +2.96% | Beat | +14.0% | 21 | 2 up, 0 down | Apr 14, 2023 | $91.93B |
| Dec 31, 2022 | $5.34 | $5.17 | $5.05 - $5.30 | +3.29% | Beat | +19.2% | 22 | 1 up, 0 down | Jan 13, 2023 | $82.79B |
| Sep 30, 2022 | $5.79 | $5.44 | $5.25 - $5.61 | +6.43% | Beat | +28.1% | 21 | 1 up, 1 down | Oct 14, 2022 | $80.89B |
| Jun 30, 2022 | $5.57 | $5.21 | N/A | +6.91% | Beat | +18.5% | N/A | 0 up, 0 down | Jul 15, 2022 | $80.33B |
| Mar 31, 2022 | $5.49 | $5.35 | $5.10 - $5.88 | +2.62% | Beat | +3.4% | 20 | 3 up, 0 down | Apr 14, 2022 | $80.15B |
| Dec 31, 2021 | $4.48 | $4.31 | $4.19 - $4.39 | +3.94% | Beat | +77.8% | 23 | 0 up, 1 down | Jan 19, 2022 | $73.74B |
| Sep 30, 2021 | $4.52 | $4.42 | $4.20 - $4.67 | +2.26% | Beat | +28.8% | 23 | N/A | Oct 14, 2021 | $72.34B |
| Jun 30, 2021 | $4.70 | $4.46 | $4.25 - $4.64 | +5.38% | Beat | -34.0% | 22 | N/A | Jul 15, 2021 | $71.32B |
| Mar 31, 2021 | $5.31 | $4.38 | $3.88 - $4.80 | +21.23% | Beat | +42.7% | 20 | N/A | Apr 15, 2021 | $70.20B |
| Dec 31, 2020 | $2.52 | $2.41 | $2.30 - $2.79 | +4.56% | Beat | -35.4% | 21 | N/A | Jan 20, 2021 | $65.47B |
| Sep 30, 2020 | $3.51 | $3.08 | $2.54 - $3.80 | +13.96% | Beat | -9.5% | 24 | N/A | Oct 14, 2020 | $65.11B |
| Jun 30, 2020 | $7.12 | $5.24 | $3.52 - $7.39 | +35.88% | Beat | +97.8% | 24 | N/A | Jul 15, 2020 | $62.14B |
| Mar 31, 2020 | $3.72 | $3.65 | $3.51 - $3.93 | +1.92% | Beat | -0.3% | 23 | N/A | Apr 15, 2020 | $64.42B |
| Dec 31, 2019 | $3.90 | $3.78 | $3.72 - $3.89 | +3.17% | Beat | +18.9% | 25 | N/A | Jan 15, 2020 | $61.28B |
| Sep 30, 2019 | $3.88 | $3.76 | $3.70 - $3.83 | +3.19% | Beat | +13.8% | 23 | N/A | Oct 15, 2019 | $60.36B |
| Jun 30, 2019 | $3.60 | $3.46 | $3.35 - $3.50 | +4.05% | Beat | +14.6% | 24 | N/A | Jul 18, 2019 | $60.61B |
| Mar 31, 2019 | $3.73 | $3.60 | $3.52 - $3.64 | +3.61% | Beat | +22.7% | 22 | N/A | Apr 16, 2019 | $59.90B |
| Dec 31, 2018 | $3.28 | $3.22 | $3.16 - $3.38 | +1.86% | Beat | +26.6% | 22 | N/A | Jan 15, 2019 | $58.40B |
| Sep 30, 2018 | $3.41 | $3.30 | $3.20 - $3.35 | +3.33% | Beat | +28.2% | 22 | N/A | Oct 16, 2018 | $56.56B |
| Jun 30, 2018 | $3.14 | $3.04 | $2.99 - $3.11 | +3.29% | Beat | +27.6% | 21 | N/A | Jul 17, 2018 | $56.09B |
| Mar 31, 2018 | $3.04 | $2.91 | $2.74 - $3.01 | +4.47% | Beat | +28.3% | 19 | N/A | Apr 17, 2018 | $55.20B |
| Dec 31, 2017 | $2.59 | $2.52 | $2.46 - $2.56 | +2.78% | Beat | +22.7% | 21 | N/A | Jan 16, 2018 | $52.07B |
| Sep 30, 2017 | $2.66 | $2.57 | $2.47 - $2.68 | +3.50% | Beat | +22.6% | 17 | N/A | Oct 17, 2017 | $50.32B |
| Jun 30, 2017 | $2.46 | $2.38 | $2.32 - $2.41 | +3.36% | Beat | +25.5% | 20 | N/A | Jul 18, 2017 | $50.05B |
| Mar 31, 2017 | $2.37 | $2.17 | N/A | +9.22% | Beat | +30.9% | N/A | N/A | Apr 18, 2017 | $48.72B |
| Dec 31, 2016 | $2.11 | $2.07 | N/A | +1.93% | Beat | +50.7% | N/A | N/A | Jan 17, 2017 | $47.53B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $16.31, down 41.1% from the year before. It was $8.05 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $16.31 | -41.1% |
| Dec 31, 2024 | $27.67 | +10.2% |
| Dec 31, 2023 | $25.12 | +13.2% |
| Dec 31, 2022 | $22.19 | +16.7% |
| Dec 31, 2021 | $19.01 | +12.7% |
| Dec 31, 2020 | $16.87 | +11.6% |
| Dec 31, 2019 | $15.11 | +17.4% |
| Dec 31, 2018 | $12.87 | +27.7% |
| Dec 31, 2017 | $10.08 | +25.2% |
| Dec 31, 2016 | $8.05 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,800 words across 23 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,802 | 23 | |
| 2026Q2 | Jun 30, 2026 | 9,384 | 21 | |
| 2026Q1 | Mar 31, 2026 | 9,234 | 21 | |
| 2025Q4 | Dec 31, 2025 | 8,375 | 18 | |
| 2025Q3 | Sep 30, 2025 | 9,171 | 25 | |
| 2025Q2 | Jun 30, 2025 | 8,645 | 14 | |
| 2025Q1 | Mar 31, 2025 | 8,942 | 21 | |
| 2024Q4 | Dec 31, 2024 | 8,697 | 17 |
2026Q3 Earnings Call
Opening remarks
Steve Hemsley Chairman and CEO Good morning, and thank you for joining us today. Our third quarter performance reflects actions taken throughout 2026, driving meaningful progress and reinforcing our confidence to sustainably grow in 2027 and beyond within our 13%-16% long-term target growth range. Our revised full-year 2026 guidance reflects continuing improvements in leadership and execution across Optum and UnitedHealthcare as we better align our businesses to serve the demands of the ever-changing U.S. healthcare environment. We are accelerating the modernization of our enterprise by advancing simplified and more responsive policies, processes, and tools, focusing on more effective integrated value-based care offerings, and responsibly building modern agentic infrastructure as we seek to ensure people have access to higher-quality care at lower costs, and at the same time, clinicians experience a simpler, faster, and more supportive system. Across the businesses, AI-enabled capabilities are beginning to help clinicians spend more time with patients, improve service speed and experience, streamline administration, and reduce friction for both consumers and clinicians. A few examples. We have expanded AI-enabled chart summarization to more than 40% of our employed clinicians, reducing chart review time by 33%. AI-enabled information gathering and research have shortened appeal cycle times by 26%, improving both member and clinician experience, and we expect this to accelerate in 2027. For this year's Medicare Advantage annual enrollment period, we are introducing AI-powered plan recommendations that use a member's care history and local plan options to help simplify their selection. By the end of this year, we are on track to implement all previously announced prior authorization reforms, reducing decision timelines for patients, relieving administrative burden for clinicians, and delivering better experiences for people. Collectively, these initiatives will reduce total prior authorizations by 30%, including a reduction of two-thirds in prior authorizations for people under the age of 18. These efforts are only the beginning. More will follow. They are central to how we're changing our enterprise to be more in line with our mission, creating greater value and positive social impact. In that vein, an important effort is the reimagined United Health Foundation. With $1 billion committed to date, the foundation's investments, along with the dedicated operational expertise of UnitedHealthcare and Optum, can help facilitate scaled solutions to some of the U.S. health system's greatest challenges, including rural health, maternal and infant health, behavioral health, and workforce education. As just one example, in Tennessee, the foundation is helping expand and operate health hubs across the state, providing underserved communities with access to preventive care and chronic condition support. We will continue to highlight the foundation as part of our commentary on our earnings calls going forward. The broader healthcare environment remains dynamic.
Frequently Asked Questions About UNH
When is UnitedHealth Group's next earnings date?
UnitedHealth Group's next earnings report is expected for Jan 25, 2027.
Did UNH beat earnings estimates last quarter?
Yes. UnitedHealth Group reported EPS of $4.69 for the quarter ended Sep 30, 2026, above the $4.12 estimate, a 13.84% surprise.
What EPS do analysts expect from UNH next quarter?
The consensus EPS estimate for UnitedHealth Group for the quarter ending Dec 31, 2026 is $2.29 from 27 analysts, with estimates from $2.11 to $2.75.
How often does UNH beat earnings estimates?
UnitedHealth Group beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +5.99%.
UNH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts